Consolidated statement of income
Download(XLS, 38 KB)| € in millions | Note | 2021 | 2020 |
|---|---|---|---|
| Sales | 4 | 37,520 | 36,277 |
| Cost of sales | -27,209 | -25,961 | |
| Gross profit | 10,311 | 10,316 | |
| Selling expenses | -1,059 | -1,057 | |
| General and administrative expenses | 8 | -4,394 | -4,373 |
| Other operating income | 9 | 381 | 398 |
| Other operating expenses | 9 | -276 | -148 |
| Research and development expenses | 7 | -805 | -751 |
| Operating income (EBIT) | 4,158 | 4,385 | |
| Interest income | 10 | 124 | 93 |
| Interest expenses | 10 | -630 | -752 |
| Income before income taxes | 3,652 | 3,726 | |
| Income taxes | 11 | -833 | -903 |
| Net income | 2,819 | 2,823 | |
| Noncontrolling interests | 12 | 1,001 | 1,116 |
| Net income attributable to shareholders of Fresenius SE & Co. KGaA | 1,818 | 1,707 | |
| Earnings per share in € | 14 | 3.26 | 3.06 |
| Fully diluted earnings per share in € | 14 | 3.26 | 3.06 |
| The following notes are an integral part of the consolidated financial statements. | |||